| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Dicker AJ, Huang J, Lonergan M, et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2021, 147(1): 158-167.
|
| 3 |
Baqdunes MW, Leap J, Young M, et al. Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J]. Crit Care Nurs Q, 2021, 44(1): 74-90.
|
| 4 |
Martinez FJ, Rabe KF, Ferguson GT, et al. Reduced all-cause mortality in the ETHOS trial of Budesonide/Glycopyrrolate/Formoterol for chronic obstructive pulmonary disease. A randomized, double-blind, multicenter, parallel-group study[J]. Am J Respir Crit Care Med, 2021, 203(5): 553-564.
|
| 5 |
Macdonald DM, Kunisaki KM, Wilt TJ, et al. Serum bilirubin and chronic obstructive pulmonary disease (COPD): a systematic review[J]. BMC Pulm Med, 2021, 21(1): 33.
|
| 6 |
Arora S, Dev K, Agarwal B, et al. Macrophages: Their role, activation and polarization in pulmonary diseases[J]. Immunobiology, 2018, 223(4-5): 383-396.
|
| 7 |
Zeng Z, He S, Lu J, et al. MicroRNA-21 aggravates chronic obstructive pulmonary disease by promoting autophagy[J]. Exp Lung Res, 2018, 44(2): 89-97.
|
| 8 |
Nurwidya F, Damayanti T, Yunus F. The role of innate and adaptive immune cells in the immunopathogenesis of chronic obstructive pulmonary disease[J]. Tuberc Respir Dis (Seoul), 2016, 79(1): 5-13.
|
| 9 |
Musri MM, Coll-Bonfill N, Maron BA, et al. MicroRNA Dysregulation in Pulmonary Arteries from Chronic Obstructive Pulmonary Disease. Relationships with Vascular Remodeling[J]. Am J Respir Cell Mol Biol, 2018, 59(4): 490-499.
|
| 10 |
Stolzenburg LR, Harris A. The role of microRNAs in chronic respiratory disease: recent insights[J]. Biol Chem, 2018, 399(3): 219-234.
|
| 11 |
张雯澜，傅丽娟，王 莹，等. 床旁肺部超声评分对机械通气患儿撤机结局的预测价值[J]. 临床儿科杂志，2020, 38(12): 900-904.
|
| 12 |
江秋霞，黄嵘森，沈龙源，等. 肺部超声新评分法评估新生儿呼吸窘迫综合征机械通气撤机时机的应用价值[J]. 临床超声医学杂志，2021, 23(4): 280-283.
|
| 13 |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志，2013, 36(4): 255-264.
|
| 14 |
床旁超声在急危重症临床应用专家共识组. 床旁超声在急危重症临床应用的专家共识[J]. 中华急诊医学杂志，2016, 25(1): 10-21.
|
| 15 |
李黎明，李莲花，关 键，等. 肺部超声评分在呼吸机相关性肺炎疗效评价中的作用[J]. 中华内科杂志，2016, 55(12): 950-952.
|
| 16 |
Villgran V, Gordon A, Malik K, et al. Comorbidities associated with chronic obstructive pulmonary disease[J]. Crit Care Nurs Q, 2021, 44(1): 103-112.
|
| 17 |
Nguyen J, Robinson DN, Sidhaye VK. Why new biology must be uncovered to advance therapeutic strategies for chronic obstructive pulmonary disease[J]. Am J Physiol Lung Cell Mol Physiol, 2021, 320(1)：1-11.
|
| 18 |
Macneil JL, Capaldi D, Westcott AR, et al. Pulmonary imaging phenotypes of chronic obstructive pulmonary disease using multiparametric response maps[J]. Radiology, 2020, 295(1): 227-236.
|
| 19 |
Olschewski H, Buhl R, Funk GC, et al. Chronic obstructive pulmonary disease: the right treatment for the right patient[J]. Internist (Berl), 2021, 62(6): 679-685.
|
| 20 |
Cagnone M, Salvini R, Bardoni A, et al. Searching for biomarkers of chronic obstructive pulmonary disease using proteomics: The current state[J]. Electrophoresis, 2019, 40(1): 151-164.
|
| 21 |
陈军喜，孙 坚. 有创呼吸机治疗慢性阻塞性肺疾病合并Ⅱ型呼吸衰竭患者撤机失败的危险因素分析[J/CD]. 中华临床医师杂志(电子版), 2013(6): 2373-2376.
|
| 22 |
甘惠玲，赵双平. APACHEⅡ评分对重症肺炎致急性肺损伤患者撤机结局的预测价值[J]. 内科急危重症杂志，2019, 25(2): 123-125.
|
| 23 |
耿兴二，唐安华. 老年重症肺炎合并呼吸衰竭患者不同撤机方式的效果比较[J/CD]. 中华肺部疾病杂志(电子版), 2018, 11(4): 456-459.
|